313 related articles for article (PubMed ID: 29912063)
1. Association of antiretroviral therapy with brain aging changes among HIV-infected adults.
Soontornniyomkij V; Umlauf A; Soontornniyomkij B; Gouaux B; Ellis RJ; Levine AJ; Moore DJ; Letendre SL
AIDS; 2018 Sep; 32(14):2005-2015. PubMed ID: 29912063
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
Slama L; Landman R; Assoumou L; Benalycherif A; Samri A; Joly V; Pialoux G; Valin N; Cabié A; Duvivier C; Lambert-Niclot S; Marcelin AG; Peytavin G; Costagliola D; Girard PM;
J Antimicrob Chemother; 2016 Aug; 71(8):2252-61. PubMed ID: 27068399
[TBL] [Abstract][Full Text] [Related]
3. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.
Brown TT; Moser C; Currier JS; Ribaudo HJ; Rothenberg J; Kelesidis T; Yang O; Dubé MP; Murphy RL; Stein JH; McComsey GA
J Infect Dis; 2015 Oct; 212(8):1241-9. PubMed ID: 25948863
[TBL] [Abstract][Full Text] [Related]
4. Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1.
Stella-Ascariz N; Montejano R; Rodriguez-Centeno J; Alejos B; Schwimmer C; Bernardino JI; Rodes B; Allavena C; Hoffmann C; Gisslén M; de Miguel R; Esteban-Cantos A; Wallet C; Raffi F; Arribas JR;
J Infect Dis; 2018 Oct; 218(10):1523-1530. PubMed ID: 29982509
[TBL] [Abstract][Full Text] [Related]
5. Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
Miro JM; Manzardo C; Ferrer E; Loncà M; Guardo AC; Podzamczer D; Domingo P; Curran A; Clotet B; Cruceta A; Lozano F; Pérez I; Plana M; Gatell JM;
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):206-15. PubMed ID: 25831464
[TBL] [Abstract][Full Text] [Related]
6. HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.
Harris M; Ganase B; Watson B; Harrigan PR; Montaner JSG; Hull MW
AIDS Res Ther; 2017 Nov; 14(1):59. PubMed ID: 29096670
[TBL] [Abstract][Full Text] [Related]
7. Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial.
Alejos B; Stella-Ascariz N; Montejano R; Rodriguez-Centeno J; Schwimmer C; Bernardino JI; Rodes B; Esser S; Goujard C; Sarmento-Castro R; De Miguel R; Esteban-Cantos A; Wallet C; Raffi F; Arribas JR;
HIV Med; 2019 Nov; 20(10):691-698. PubMed ID: 31532902
[TBL] [Abstract][Full Text] [Related]
8. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Molina JM; Squires K; Sax PE; Cahn P; Lombaard J; DeJesus E; Lai MT; Rodgers A; Lupinacci L; Kumar S; Sklar P; Hanna GJ; Hwang C; Martin EA;
Lancet HIV; 2020 Jan; 7(1):e16-e26. PubMed ID: 31740348
[TBL] [Abstract][Full Text] [Related]
9. Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study.
Chaudhary NS; Kind T; Willig AL; Saag MS; Shrestha S; Funderburg N; Wiener HW; Overton ET; Irvin MR
Medicine (Baltimore); 2021 Jul; 100(30):e26588. PubMed ID: 34397689
[TBL] [Abstract][Full Text] [Related]
10. Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.
Pulido F; Ribera E; Lagarde M; Pérez-Valero I; Palacios R; Iribarren JA; Payeras A; Domingo P; Sanz J; Cervero M; Curran A; Rodríguez-Gómez FJ; Téllez MJ; Ryan P; Barrufet P; Knobel H; Rivero A; Alejos B; Yllescas M; Arribas JR;
Clin Infect Dis; 2017 Nov; 65(12):2112-2118. PubMed ID: 29020293
[TBL] [Abstract][Full Text] [Related]
11. Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study.
Dai L; Liu A; Zhang H; Wu H; Zhang T; Su B; Shao Y; Li J; Ye J; Scott SR; Mahajan SD; Schwartz SA; Yu H; Sun L
Curr HIV Res; 2019; 17(5):324-334. PubMed ID: 31654514
[TBL] [Abstract][Full Text] [Related]
12. Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized study.
Saumoy M; Ordóñez-Llanos J; Martínez E; Ferrer E; Domingo P; Ribera E; Negredo E; Curto J; Sánchez-Quesada JL; Di Yacovo S; González-Cordón A; Podzamczer D
J Antimicrob Chemother; 2015 Apr; 70(4):1130-8. PubMed ID: 25538166
[TBL] [Abstract][Full Text] [Related]
13. Simplification from twice-daily to once-daily darunavir/ritonavir in a randomized trial among HIV-infected persons with HIV-1 RNA suppression on antiretroviral therapy.
Huhn GD; Sigman A; Livak B
Antivir Ther; 2015; 20(8):849-54. PubMed ID: 25881614
[TBL] [Abstract][Full Text] [Related]
14. Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults.
Soontornniyomkij V; Umlauf A; Soontornniyomkij B; Batki IB; Moore DJ; Masliah E; Achim CL
J Neurovirol; 2016 Oct; 22(5):650-660. PubMed ID: 27098516
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up of patients enrolled in the NEAT 001/ANRS 143 randomized clinical trial: NEAT 001/ANRS 143 LONG TERM study.
Raffi F; Gaultier A; Pozniak A; Molina JM; Jessen H; Antinori A; Soria A; Cavellec M; Le Thuaut A; Ningre M; de Wit S
J Antimicrob Chemother; 2020 Jun; 75(6):1618-1622. PubMed ID: 32211883
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitors and preterm delivery: another piece in the puzzle.
Favarato G; Townsend CL; Bailey H; Peters H; Tookey PA; Taylor GP; Thorne C
AIDS; 2018 Jan; 32(2):243-252. PubMed ID: 29135577
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.
Brogan AJ; Smets E; Mauskopf JA; Manuel SA; Adriaenssen I
Pharmacoeconomics; 2014 Sep; 32(9):903-17. PubMed ID: 24906477
[TBL] [Abstract][Full Text] [Related]
18. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.
Grinsztejn B; Hughes MD; Ritz J; Salata R; Mugyenyi P; Hogg E; Wieclaw L; Gross R; Godfrey C; Cardoso SW; Bukuru A; Makanga M; Faesen S; Mave V; Wangari Ndege B; Nerette Fontain S; Samaneka W; Secours R; van Schalkwyk M; Mngqibisa R; Mohapi L; Valencia J; Sugandhavesa P; Montalban E; Avihingsanon A; Santos BR; Kumarasamy N; Kanyama C; Schooley RT; Mellors JW; Wallis CL; Collier AC;
Lancet HIV; 2019 Sep; 6(9):e588-e600. PubMed ID: 31371262
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
Bernardino JI; Mocroft A; Mallon PW; Wallet C; Gerstoft J; Russell C; Reiss P; Katlama C; De Wit S; Richert L; Babiker A; Buño A; Castagna A; Girard PM; Chene G; Raffi F; Arribas JR;
Lancet HIV; 2015 Nov; 2(11):e464-73. PubMed ID: 26520926
[TBL] [Abstract][Full Text] [Related]
20. Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
Santos JR; Llibre JM; Berrio-Galan D; Bravo I; Miranda C; Pérez-Alvarez S; Pérez-Alvarez N; Paredes R; Clotet B; Moltó J
J Antimicrob Chemother; 2015 Apr; 70(4):1124-9. PubMed ID: 25525196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
